BOEHRINGER INGELHEIM INTERNATIONAL GMBH

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 60816
 
  
 
C07D HETEROCYCLIC COMPOUNDS 5718
 
  
 
A61M DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY 11659
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 9225
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 754
 
  
 
C07K PEPTIDES 6573
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 50117
 
  
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 4593
 
  
 
B05B SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES 3532
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 32174

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0028,451 IMMEADIATE RELEASE ORAL TABLETFeb 24, 16Feb 01, 18[A61K]
2018/0009,887 METHODS OF TREATING DISEASESAug 25, 17Jan 11, 18[A61K, C07K]
2018/0002,312 TETRA- AND PENTASUBSTITUTED BENZIMIDAZOLIUM COMPOUNDS USEFUL IN THE TREATMENT OF RESPIRATORY DISEASESJan 07, 16Jan 04, 18[A61K, C07F, C07D]
2017/0298,126 METHODS OF TREATING INFLAMMATORY DISEASESApr 13, 17Oct 19, 17[C12Q, C07K]
2017/0266,152 PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOFMar 13, 17Sep 21, 17[A61K]
2017/0203,056 DRUG DELIVERY DEVICEJul 24, 15Jul 20, 17[A61M]
2017/0128,680 SYSTEM WITH NEBULIZER AND CONTAINERNov 04, 16May 11, 17[B05B, G01D, A61M]
2017/0128,681 NEBULIZER AND CONTAINERNov 08, 16May 11, 17[B05B, A61M]
2017/0106,009 METHODS OF TREATING DISEASESOct 13, 16Apr 20, 17[A61K]
2017/0107,281 ANG2-BINDING MOLECULESDec 21, 16Apr 20, 17[A61K, C07K]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9920035 Heterocyclic compounds, medicaments containing said compounds, use thereof and processes for the preparation thereofAug 05, 15Mar 20, 18[C07D]
9914735 Heteroaryl Syk inhibitorsMar 12, 15Mar 13, 18[A61K, C07D]
9907756 Capsule pharmaceutical dosage form comprising a suspension formulation of an indolinone derivativeJul 07, 16Mar 06, 18[A61K]
9890171 Aldosterone synthase inhibitorsDec 01, 15Feb 13, 18[A61K, C07D, A61P]
9884854 N-[(pyrimidinylamino)propanyl]-and N[(pyrazinylamino)proppanyl]arylcarboxamidesApr 12, 17Feb 06, 18[C07D]
9879026 Substituted spirocyclesNov 29, 16Jan 30, 18[A61K, C07D]
9873714 Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivativesApr 07, 15Jan 23, 18[C07H, C07D]
9867831 Combination treatment of acute myeloid leukemia and myelodysplastic syndromeSep 21, 15Jan 16, 18[A61K]
9845314 Pyrazolyl-substituted heteroaryls and their use as medicamentsSep 02, 16Dec 19, 17[A61K, C07D]
9840543 Anti-BAFF antibodiesJan 30, 15Dec 12, 17[A61K, C07K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0088,609 ANTICANCER COMBINATION THERAPYAbandonedSep 27, 16Mar 30, 17[A61K, C07K]
2017/0050,992 NOVEL ANNELATED PHENOXYACETAMIDESAbandonedAug 19, 16Feb 23, 17[A61K, C07F, C07D, C07C]
2016/0304,602 METHODS OF TREATING DISEASESAbandonedApr 13, 16Oct 20, 16[C07K]
2016/0106,837 COMBINATION OF CD37 ANTIBODIES WITH CHLORAMBUCILAbandonedJun 14, 13Apr 21, 16[A61K]
2016/0052,938 SPIRO[3H-INDOLE-3,2'-PYRROLIDIN]-2(1H)-ONE COMPOUNDS AND DERIVATIVES AS MDM2-P53 INHIBITORSAbandonedAug 20, 15Feb 25, 16[A61K, C07D]
2016/0045,436 PHARMACEUTICAL FORMULATIONAbandonedAug 14, 15Feb 18, 16[A61K, A61M]
2016/0032,006 THERAPEUTIC AND DIAGNOSTIC TARGET FOR CANCER COMPRISING DLL3 BINDING REAGENTSAbandonedFeb 12, 14Feb 04, 16[A61K, G01N, C07K]
2016/0016,990 PROTEIN PURIFICATION BY MEANS OF AQUEOUS TWO-PHASE CENTRIFUGAL EXTRACTIONAbandonedFeb 26, 14Jan 21, 16[C07K, B01D]
2016/0000,816 PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOFAbandonedSep 16, 15Jan 07, 16[A61K]
2015/0368,230 RADIOLABELED QUINAZOLINE DERIVATIVESAbandonedJan 28, 14Dec 24, 15[A61K, C07D]
2015/0150,982 PHARMACEUTICAL FORMULATION FOR A THERAPEUTIC ANTIBODYAbandonedJun 12, 13Jun 04, 15[A61K, C07K]
2015/0140,591 CELL ENGINEERING USING RNAsAbandonedJun 04, 13May 21, 15[C12P, C12N, C07K]
2015/0141,651 HEXAHYDROINDENOPYRIDINE DERIVATIVESAbandonedNov 19, 14May 21, 15[C07D]
2015/0051,208 PYRIDINONESAbandonedAug 11, 14Feb 19, 15[C07D]
2015/0041,558 NEBULIZERAbandonedAug 07, 14Feb 12, 15[B05B, A61M]
2015/0038,532 Pharmaceutical Composition Of A Potent HCV Inhibitor For Oral AdministrationAbandonedOct 17, 14Feb 05, 15[A61K]
2015/0031,642 COMBINATION TREATMENT OF ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME IAbandonedJul 24, 14Jan 29, 15[A61K]
2015/0031,643 COMBINATION TREATMENT OF ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME IIAbandonedJul 24, 14Jan 29, 15[A61K]
2015/0031,699 TREATMENT OF MYELODYSPLASTIC SYNDROMEAbandonedJul 24, 14Jan 29, 15[A61K]
2015/0005,350 ADMINISTRATION OF ETHYL 3-[(2--1-METHYL-1H-BENZIMIDAZOL-5-CARBONYL)PYRIDIN-2-YLAMINO]PROPIONATEAbandonedSep 18, 14Jan 01, 15[A61K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.